RADIATION DIAGNOSTICS IN MAMMOLOGY
Keywords:
Breast cancer, mammograms, MRI, screening, biopsy.Abstract
Breast cancer is the most common cancer in females worldwide, accounting for nearly one-fourth of newly diagnosed cancers in Fergana Valley. Nearly half of women in Fergana valley develop breast cancer at the age of 50 years versus the age of 65 years . In developing countries, a large number of women are still diagnosed at a later stage in comparison to developed countries where early detection is made through organized screening programs. The number of breast cancer cases in Asia has increased with higher rates in the Eastern region (26.6 out of 100 000 women) compared with other regions. Nearly one-third of women develop breast cancer younger than the age of 50 years. Various studies have highlighted risk factors that could be related to the increase in breast cancer incidence in Central Asia. Screening with mammography for breast cancer detection has already become the standard community practice in many countries. Other imaging modalities that can be helpful diagnostic tools (like ultrasound or magnetic resonance imaging) are not feasible for general screening purposes due to inherent limitations (operator dependency and lack of recognizing microcalcifications with ultrasound, claustrophobia and contrast-related concerns with MRI) and cost (especially with MRI).We aim to highlight various causes of missed screening-detected incident breast cancers (i.e., cancers diagnosed on a second or subsequent screen in women after initial or baseline negative studies), and to emphasize measures that could overcome weaknesses in the chain of events.
References
Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, Baade PD. 2012. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol 36:237–248. 10.1016/j.canep.2012.02.007
Saggu S, Rehman H, Abbas ZK, Ansari AA. 2015. Recent incidence and descriptive epidemiological survey of breast cancer in Saudi Arabia. Saudi Med J 36:1176–1180. 10.15537/smj.2015.10.12268
Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ. 2014. Feb;348 feb11 9:g366. 10.1136/bmj.g366
Alghamdi IG, Hussain II, Alghamdi MS, El-Sheemy MA. 2013. The incidence rate of female breast cancer in Saudi Arabia: an observational descriptive epidemiological analysis of data from Saudi Cancer Registry 2001-2008. Breast Cancer (Dove Med Press) 5:103–109. 10.2147/BCTT.S50750
Almutlaq BA, Almuazzi RF, Almuhayfir AA, Alfouzan AM, Alshammari BT, AlAnzi HS, Ahmed HG. 2017. Breast cancer in Saudi Arabia and its possible risk factors. J Cancer Policy 12:83–89. 10.1016/j.jcpo.2017.03.004.
Al-Amoudi SM, Sait WA, Abduljabbar HS. 2010. Health care provider's role in facing the future burden of breast cancer in Saudi. Saudi Med J 31:1359–1362.
El Bcheraoui C, Basulaiman M, Wilson S, Daoud F, Tuffaha M, AlMazroa MA, Memish ZA, Al Saeedi M, Mokdad AH. 2015. Breast cancer screening in Saudi Arabia: free but almost no takers. PLoS One 10:e0119051. 10.1371/journal.pone.0119051